Frazier Life Sciences Management, L.P. Imago Bio Sciences, Inc. Transaction History

Frazier Life Sciences Management, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 03, 2023	BUY	$15.03 - $35.96 $15.3 Million - $36.5 Million	1,015,933 Added 34.19%	3,987,207 $143 Million
Q1 2022 May 16, 2022	BUY	$16.97 - $25.0 $50.4 Million - $74.3 Million	2,971,274 New	2,971,274 $57.3 Million

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Frazier Life Sciences Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Frazier Life Sciences Management, L.P. with notifications on news.